IP Verse

Wittkopp patent opposition analysis

Get complete Patent Opposition Report for Wittkopp

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Latest oppositions filed by Wittkopp

Explore patent oppositions filed by Wittkopp against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent NumberTitleApplicantOpposition Date
EP2925324Trans-4-{2-[4-(2,3-Dichlorophenyl)-Piperazin-1-Yl]-Ethyl}-N,N-Dimethylcarbamoyl-Cyclohexylamine For Treating Negative Symptoms Of SchizophreniaRICHTER GEDEON NYRTSep 29, 2021
EP3246021Apixaban FormulationsBRISTOL MYERS SQUIBB IRELANDAug 7, 2020
EP2684565Use Of Ulipristal Acetate For Treating Uterine FibroidsLABORATOIRE HRA PHARMAJul 2, 2020
EP2805712Heat Sterilization Of GlucocorticoidsteriodsNORTON HEALTHCARENov 27, 2018
EP1687019Propylene Glycol-Containing Peptide Formulations Which Are Optimal For Production And For Use In Injection DevicesNOVO NORDISKAug 21, 2018
EP2793618Methods For Purifying Steviol Glycosides And Uses Of The SamePURECIRCLE SDN BHDAug 9, 2018
EP2217214Pharmaceutical Formulation Comprising EzetimibeRATIOPHARMApr 19, 2018
EP3050556Process For Manufacturing A Pharmaceutical Preparation Containing Glatiramer AcetateTEVA PHARMACEUTICAL INDUSTRIESDec 21, 2017
EP2056832Compositions, Suitable For Oral Administration, Comprising A Triazolo [4, 5-D]Pyrimidin DerivateASTRAZENECADec 18, 2017
EP2269603Treatment Of Solid Tumours With Rapamycin DerivativesNOVARTISFeb 22, 2016

Top competitors of Wittkopp